-
-
155
-
Diversified investments
-
- Insights
- Capabilities
- Funds
- Sustainability
- About Us
- My Account
155
Diversified investments
Average core investment team years' experience2
$7.9B
AUM (USD)1
Our Private Equity Team includes specialists who draw on their backgrounds as entrepreneurs, doctors, and scientists. We tap into our firm’s broad investment capabilities, and believe our reputation, deep industry expertise, and asset size attract a wide range of potential private investments.
Our Private Equity Team works closely with portfolio managers, global industry analysts, and other global research resources within Wellington to identify and pursue investments in private companies. We can put capital to work quickly and invest in a wide range of deals across the private market spectrum. We have the ability to invest in both small private companies as well as participate in large capital raises. We seek to invest in companies with strong management teams who are looking for capital to fund future growth. In addition to capital support, we offer strategic guidance based on industry experience and can provide insights into the public market.
We aim to use our global scale, sector expertise, and market reach to help partner with innovative, disruptive companies in the private market. Today, we invest globally and focus on consumer, technology, health care, biotechnology and financial services.
We think the private equity market environment is providing attractive opportunities for capital appreciation, and that our firm is well positioned to pursue them — serving not only as a capital provider, but potentially also as an experienced intellectual partner. We have the ability to provide support and guidance through the phases of a company’s business cycle. We strive to partner with entrepreneurs who embrace that challenge and want an investor who shares their vision and desire to build great companies.
Digital technology is changing the way consumer products are marketed and sold, paving the way for the next generation of consumer brands and technologies.
Data analytics, social features, and cloud technologies are transforming companies’ abilities to meet customer needs by potentially reducing costs and expanding reach. We believe the future is data-rich, online, on-demand, and mobile.
Advancements in drug discovery, applied science, and health care services are improving patient outcomes. Innovation in health care is changing lives.
We believe developments in digital banking are changing the face of finance. Banking services, lending, and payments are driving global growth and collaboration.
Significant scientific advances have unearthed fundamental pathways of disease and potential strategies for interdiction. Drug pipelines are ripe with exciting new products on the horizon. Supported by structural and regulatory tailwinds, we believe we are in the midst of a potentially unprecedented period of drug discovery.
Climate change is the defining challenge of our time, with profound and far-reaching implications. The market opportunity for mitigation- and adaptation-related climate solutions is enormous and necessary.
As of 30 April 2023
Emily Bannister, CFA
Industry experience: 21 years
With Wellington: 9 year
Molly Breiner
Industry experience: 16 years
With Wellington: 2 year
Michael Carmen
Industry experience: 34 years
With Wellington: 24 years
Ross Castillo, MD
Industry experience: 7 years
With Wellington: < 1 year
Cindy Cheng
Industry experience: 12 years
With Wellington: 3 years
William Craig
Industry experience: 16 years
With Wellington: 1 year
Jackson Cummings
Industry experience: 9 years
With Wellington: 2 year
Mike DeLucia
Industry experience: 16 years
With Wellington: 2 year
Caitlin Ferris
Industry experience: 3 years
With Wellington: < 1 year
Hillary Flynn
Industry experience: 15 years
With Wellington: 13 years
Frederik Groce
Industry experience: 9 years
With Wellington: 2 year
Cara Hubbard
Industry experience: 20 years
With Wellington: 6 years
Michelle Hunter, CFA
Industry experience: 19 years
With Wellington: 17 years
Van Jones
Industry experience: 14 years
With Wellington: 2 year
Nilesh Kumar, PhD
Industry experience: 17 years
With Wellington: 2 year
Ryan Lewis, CFA, CAIA
Industry experience: 10 years
With Wellington: 2 year
Matt Lipton
Industry experience: 17 years
With Wellington: 7 years
Irina Margine, PhD
Industry experience: 9 years
With Wellington: 3 years
Rob Mazzoni
Industry experience: 18 years
With Wellington: <1 years
Sasha McKenzie
Industry experience: 13 years
With Wellington: 2 year
AJ McGuire, CMT
Industry experience: 20 years
With Wellington: 4 years
Nelson McNeil
Industry experience: 14 years
With Wellington: 2 year
Drew Morales
Industry experience: 10 years
With Wellington: 3 years
Osman Nur
Industry experience: 7 years
With Wellington: <1 years
Shanna O'Reilly
Industry experience: 22 years
With Wellington: 18 years
Oyin Oduya
Industry experience: 14 years
With Wellington: 2 year
Emeka Onukwugha
, CFA
Industry experience: 36 years
With Wellington: < 1 year
Yash Patodia
Industry experience: 15 years
With Wellington: 9 years
Elisabeth Perenick
, FSA, CFA
Industry experience: 29 years
With Wellington: < 1 year
Sean Petersen
Industry experience: 26 years
With Wellington: 2 year
Jose Gonzalez Rico
Industry experience: 11 years
With Wellington: 1 year
I-hung Shih
Industry experience: 22 years
With Wellington: 4 years
Prakhar Singh
Industry experience: 12 years
With Wellington: 3 years
Owen Sirianni
Industry experience: 5 years
With Wellington: < 1 year
Josh Sommerfeld
Industry experience: 15 years
With Wellington: 3 years
Greg Wasserman
Industry experience: 23 years
With Wellington: 2 year
Mark Watson
Industry experience: 5 years
With Wellington: 1 year
Matthew Witheiler
Industry experience: 18 years
With Wellington: 7 years
Jenny Xie
Industry experience: 4 years
With Wellington: 4 year
Fixed income and currency approaches with an absolute return style.
Subscribe now to receive our monthly newsletter and stay abreast of the latest trends, brought to you directly from our investment experts.
This reflects substantially all portfolio company investments made by Wellington Management’s dedicated private equity funds, excluding investments made by the Wellington Access Venture team. Due to confidentiality restrictions, one company name cannot be disclosed. Additional information is available upon request. It should not be assumed that an investment in the portfolio companies identified was or will be profitable. As of 30 April 2023.
1 As of 30 April 2023. This reflects the committed capital of, and investments made by, dedicated private equity funds, and a special purpose “warehousing” vehicle formed to hold certain investments prior to close.
2 Reflects general investment industry experience.
Wellington Management Company LLP (WMC) is an independently owned investment adviser registered with the US Securities and Exchange Commission (SEC). WMC is also a commodity trading advisor (CTA) registered with the US Commodity Futures Trading Commission. In certain circumstances, WMC provides commodity trading advice to clients in reliance on exemptions from CTA registration. In the US for ERISA clients, WMC is providing this material solely for sales and marketing purposes and not as an investment advice fiduciary under ERISA or the Internal Revenue Code. WMC has a financial interest in offering its products and services and is not committing to provide impartial investment advice or give advice in a fiduciary capacity in connection with those sales and marketing activities. WMC, along with its affiliates (collectively, Wellington Management), provides investment management and investment advisory services to institutions around the world. Located in Boston, Massachusetts, Wellington Management also has offices in Chicago, Illinois; Radnor, Pennsylvania; San Francisco, California; Beijing; Frankfurt; Hong Kong; London; Luxembourg; Singapore; Sydney; Tokyo; Toronto; and Zurich. ■ This material is prepared for, and authorized for internal use by, designated institutional and professional investors and their consultants or for such other use as may be authorized by Wellington Management. This material and/or its contents are current at the time of writing and may not be reproduced or distributed in whole or in part, for any purpose, without the express written consent of Wellington Management. This material is not intended to constitute investment advice or an offer to sell, or the solicitation of an offer to purchase shares or other securities. Investors should always obtain and read an up-to-date investment services description or prospectus before deciding whether to appoint an investment manager or to invest in a fund. Any views expressed herein are those of the author(s), are based on available information, and are subject to change without notice. Individual portfolio management teams may hold different views and may make different investment decisions for different clients.
Private biotech market: Innovation, valuations, and capital efficiency
Co-heads of biotech private investments I-hung Shih and Nilesh Kumar join host Thomas Mucha to explore today's private biotech market, highlighting the state of deal flow, valuations, and innovation.
How do bank failures impact fintech?
Global Industry Analyst Matt Ross analyzes the ways in which recent US bank failures could impact the fintech sector in public and private markets.
Cybersecurity for private companies
We highlight today's rising cybersecurity risks, explore how they impact private companies, discuss key regulatory considerations, and share best practices for companies facing these threats.
Private biotech: Innovation amid disruption
We explore the state of the private biotech market, highlight key areas of innovation, and share three themes we expect to continue.
Private placement amid today’s financial distress
We explore how today's challenging environment impacts private credit markets, including its effects on spreads, issuance, and terms.
The denominator effect: Thoughts on the rise in private equity allocations
The sharp drop in public markets has left many asset owners with above-target exposure to private assets, raising a number of governance questions. Multi-Asset Strategist Adam Berger considers the likely responses and their potential pros and cons.
Private equity market in 2023
In the first episode of WellSaid Season 2, Co-Head of Private Investing Michael Carmen joins host Thomas Mucha to share his constructive outlook for today's rapidly evolving private market landscape. In addition, they discuss the role of ESG in privates, how Wellington collaborates with entrepreneurs, and much more.
The role of ESG in fintech
Global Industry Analyst Matt Ross and Portfolio Manager Matt Lipton explore the role of ESG in fintech in this clip from their WellSaid podcast episode.
Picture this: Our 2023 economic forecast in five charts
We explain the shifts the market is undergoing, analyze the implications for different asset classes, and identify potential risks and opportunities in a series of visuals.
Human capital management for private companies
We discuss why effective people management is critical for private companies and outline four strategic focus areas that can help companies navigate evolving employee needs, regulatory changes, and investor expectations.
URL References
Related Insights